Regulus Therapeutics Inc. (RGLS) Fell -32.31% or -0.4 To Price $0.85 On Thursday


Regulus Therapeutics Inc. (RGLS) fell -32.31% or -0.4 to $0.85. It is near to 5.53 million shares traded, which is 1529.11% compare to the average total volume 361690. The market cap of RGLS is $87.96 million. The year to date change is 10.62%. The 52 week price range is from $0.79 to $1.95. Price of RGLS have changed 15.74% during last week. It have changed 8.70% over last month, 40.47% over last 3 months, 30.07% over last 6 months and 11.11% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RGLS is 1.20. It is 41.18% above current price. The 200-day Moving Averages for RGLS is 1.12. It is 31.76% above current price. The 52-week High is 1.95. It is 129.41% from the current price. The 52-week Low is 0.79. It is -7.06% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of RGLS is 4.08 on 2018-02-15. Short % to float is 2.07%. There are some statistics of RGLS. It is has market cap $87.96 million. The share outstanding is 103.96 million. The average volume is 361690. The revenue is 72000. The percent of top 15 Institution holding is 34.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RGLS is -127.78%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RGLS is -74.82%.


Tags:

Share this post